Ribbon Biolabs
DNA synthesis company
Ribbon Biolabs has raised €18M across 1 funding round from 5 investors, most recently a Series A round in Jan 2022. Based in Vienna, Austria; active in Healthtech. Data as of 4 Nov 2026.
Vienna, Austriaribbonbiolabs.com ↗
Total raised
€18M
€18,000,000
Funding rounds
1
Investors
5
distinct backers
Active since
2022-01
latest 2022-01
Funding by year
EUR raised per yearRibbon Biolabs — funding by year — interactive chart.
Data table
| Ribbon Biolabs — funding by year | |
|---|---|
| 2022 | €18M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-31 | Series A | €18M | Hadean Ventures,Helicase Venture,IST cube,Lansdowne Partners,Tecnet equity | View deal → |
Related news
- Ribbon Biolabs Raises EUR18M in Series A Financingfinsmes.com · 2022-02
Similar companies
same sector, similar size- Oncoone€13MAustria · Healthtech
- Platomics€14MAustria · Healthtech
- nyra health€25MAustria · Healthtech
- Gaia€18MUK · Healthtech
- Moka.care€18MFrance · Healthtech
- Pleco Therapeutics€17MNetherlands · Healthtech
Global coverage: FundingData